Consideration of Kinase Inhibitors for the Treatment of Hydrocephalus

por Blazer-Yost, Bonnie L.
Publicado 2023

PPARγ Agonists: Blood Pressure and Edema

por Blazer-Yost, Bonnie L.
Publicado 2010

Hydrocephalus: historical analysis and considerations for treatment

por Hochstetler, Alexandra, Raskin, Jeffrey, Blazer-Yost, Bonnie L.
Publicado 2022

Bioinformatic Analysis of Differential Protein Expression in Calu-3 Cells Exposed to Carbon Nanotubes

por Li, Pin, Lai, Xianyin, Witzmann, Frank A., Blazer-Yost, Bonnie L.
Publicado 2013

A human polymorphism affects NEDD4L subcellular targeting by leading to two isoforms that contain or lack a C2 domain

por Garrone, Nicholas F, Blazer-Yost, Bonnie L, Weiss, Robert B, Lalouel, Jean-Marc, Rohrwasser, Andreas
Publicado 2009

Kinase Inhibitors in Genetic Diseases

por D’Antona, Lucia, Amato, Rosario, Brescia, Carolina, Rocca, Valentina, Colao, Emma, Iuliano, Rodolfo, Blazer-Yost, Bonnie L., Perrotti, Nicola
Publicado 2023

Pioglitazone Attenuates Cystic Burden in the PCK Rodent Model of Polycystic Kidney Disease

por Blazer-Yost, Bonnie L., Haydon, Julie, Eggleston-Gulyas, Tracy, Chen, Jey-Hsin, Wang, Xiaofang, Gattone, Vincent, Torres, Vicente E.
Publicado 2010

TRPV4 antagonists ameliorate ventriculomegaly in a rat model of hydrocephalus

por Hochstetler, Alexandra E., Smith, Hillary M., Preston, Daniel C., Reed, Makenna M., Territo, Paul R., Shim, Joon W., Fulkerson, Daniel, Blazer-Yost, Bonnie L.
Publicado 2020

Inhibition of serum- and glucocorticoid-induced kinase 1 ameliorates hydrocephalus in preclinical models

por Hochstetler, Alexandra, Smith, Hillary, Reed, Makenna, Hulme, Louise, Territo, Paul, Bedwell, Amanda, Persohn, Scott, Perrotti, Nicola, D’Antona, Lucia, Musumeci, Francesca, Schenone, Silvia, Blazer-Yost, Bonnie L.
Publicado 2023

Hydrocephalus in a rat model of Meckel Gruber syndrome with a TMEM67 mutation

por Shim, Joon W., Territo, Paul R., Simpson, Stefanie, Watson, John C., Jiang, Lei, Riley, Amanda A., McCarthy, Brian, Persohn, Scott, Fulkerson, Daniel, Blazer-Yost, Bonnie L.
Publicado 2019

A randomized phase 1b cross-over study of the safety of low-dose pioglitazone for treatment of autosomal dominant polycystic kidney disease

por Blazer-Yost, Bonnie L, Bacallao, Robert L, Erickson, Bradley J, LaPradd, Michelle L, Edwards, Marie E, Sheth, Nehal, Swinney, Kim, Ponsler-Sipes, Kristen M, Moorthi, Ranjani N, Perkins, Susan M, Torres, Vicente E, Moe, Sharon M
Publicado 2021